Trump Family's 'Health Plan': Just Another Branding Opportunity
MSNBC's piece on 'TrumpRx' highlights how the Trump family might 'reap major rewards' from the former president's prescription drug initiative. This observation, while accurate, sidesteps the fundamental truth that for the Trump organization, the presidency itself was a branding exercise. From Mar-a-Lago hosting foreign dignitaries charging exorbitant rates to Ivanka Trump's trademarks approved in
China, every aspect of his administration bore the unmistakable scent of personal enrichment. This wasn't an anomaly; it was the entire business model. One might wonder why MSNBC treats this as a 'could reap' scenario rather than pointing out a consistent pattern of blurring public office with private gain. The 'TrumpRx' plan, connecting to companies like Blink Health (which has a history with
Kushner's ventures), isn't a new ethical frontier. It’s simply another iteration of the family's approach: the presidency as a launchpad for brand expansion. The 'rewards' aren't hypothetical; they're the expected outcome when the line between state and personal assets dissolves. It’s what happens when 'Make America Great Again' becomes 'Make the Trumps Rich Again.'